Treatment of cervicothoracic pain and cervicogenic headaches with regenerative injection therapy.
Curr Pain Headache Rep. 2004 Feb;8(1):41-8.Treatment of cervicothoracic pain and cervicogenic headaches with regenerative injection therapy.
Linetsky FS, Miguel R, Torres F. Nova Southeastern College of Osteopathic Medicine, 34672 US 19 N, Palm Harbor, FL 34684, USA. prolopain@aol.com
Abstract
Significant progress has been made in interventional pain management. Despite this progress, patients continue to present a diagnostic
and therapeutic challenge. Steroidal and nonsteroidal anti-inflammatory medications have limited use in degenerative painful conditions
of connective tissue. Regenerative injection therapy, also known as prolotherapy, is a viable, type-specific treatment for such pathology.
Several placebo-controlled studies, together with uncontrolled studies, indicate the effectiveness of regenerative injection therapy in
treating painful ligament and tendon pathology. As stated in July 2003 by Mooney, this treatment has advanced "from the fringe to the
frontier of medical care." PMID: 14731382 [PubMed - indexed for MEDLINE
Hauser R, Hauser M. Dextrose Prolotherapy for Unresolved Neck Pain, Practical Pain Management, October 2007
ABSTRACT AND INTRODUCTION:
The optimal long-term, symptomatic therapy for chronic neck pain has not been established. Accordingly, we
investigated the outcomes of patients undergoing Hemwall-Hackett dextrose Prolotherapy treatment for unresolved neck
pain at a charity clinic in rural Illinois. We studied a sample of 98 patients who had suffered with pain on average
for 59 months and seen over 3 physicians prior to being treated quarterly with Prolotherapy. On average 18 months following
their last Prolotherapy session, patients were contacted and asked numerous questions in regard to their levels of pain
and a variety of physical and psychological symptoms, as well as activities of daily living, before and after their last Prolotherapy treatment.
RESULTS: The results of this study showed that patients had a statistically significant decline in their level of pain, stiffness and
crunching sensation with Prolotherapy. This included clients who were told by their M.D. (s) that there were no other treatment options or
that surgery was their only answer for their chronic pain. More than 83% of patients showed improvements in walking ability, exercise ability,
anxiety, depression and overall disability with Prolotherapy. Ninety percent of patients who were on medications at the start of Prolotherapy
were able to cut their pain medication usage by 50% or more. Additional pain management care was able to be lessened by 50% or more in 75% of
cases with Prolotherapy. Ninety-eight percent of patients stated their pain was better with Prolotherapy. Ninety-seven percent of patients said
Prolotherapy changed their life for the better.